ByHeart, Inc.
Medical device company · New York, United States
ByHeart, Inc. is a medical device company headquartered in New York, United States. Its earliest recorded incorporation is in 2017. It has reported private securities offerings to the US SEC, most recently $95 million sold in a notice filed in 2026.
ByHeart at a glance
What does ByHeart do?
Private fundraising reported to the SEC
10 Form D notices; the most recent reported $95.5 million sold (2026).
Frequently asked questions about ByHeart
Where is ByHeart headquartered?
ByHeart, Inc. is headquartered in New York, United States.
What does ByHeart do?
ByHeart, Inc. is a medical device company.
When was ByHeart founded?
The earliest incorporation on record for ByHeart, Inc. is in 2017, according to public company registers.
Similar companies
- PAVmed Inc.New York City, New York, United States
- Lucid Diagnostics Inc.New York City, New York, United States
- Intelligent Bio Solutions Inc.New York City, New York, United States
- Fisher Wallace Laboratories, Inc.New York City, New York, United States
- Microstructure Imaging, Inc.New York City, New York, United States
- Addinex Technologies, Inc.New York City, New York, United States
- Spark Neuro Inc.New York City, New York, United States
- Hyprevention Inc.New York City, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences